| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.52B | $2.40B | $2.20B |
| YoY Revenue Growth % | +4.8% | +9.0% | — |
| Gross Profit | $1.79B | $1.69B | — |
| Gross Margin % | 71.2% | 70.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $120.6M | $2.7M | -$198.8M |
| Operating Margin % | 4.8% | 0.1% | -9.0% |
| Net Income (GAAP) | $43.4M | -$58.3M | -$165.2M |
| EBITDA (Normalized) | $144.6M | $22.7M | -$119.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $617.4M | $483.3M | $399.7M |
| Capital Expenditures (CapEx) | $30.1M | $25.0M | $99.1M |
| Free Cash Flow (FCF) | $587.3M | $458.3M | $300.6M |
| FCF Margin % | 23.4% | 19.1% | 13.6% |
| Return on Invested Capital (ROIC %) | 95.0% | 0.4% | -6.7% |
| Cash & Short-Term Equivalents | $132.6M | $242.8M | — |
| Total Debt (Short + Long Term) | $629.6M | $1.35B | $909.8M |
| Total Stockholders' Equity | -$588.1M | -$550.9M | $1.87B |